Contact
Please use this form to send email to PR contact of this press release:
FDA Grants Orphan Drug Designation to NovelWise’s NBM-BMX for Uveal Melanoma
TO:
Annie Pai
NovelWise Pharmaceutical Corporation USA
+1 910-297-9045